application
to the order of the Russian Federation Ministry of Health
on November 9, 2012 № 799n
Standard of specialized medical care for children with viral gastroenteritis-severe
Age category: children
Floor: any
Phase: acute
Stage: heavy severity
complications: regardless of the complications
Type of medical care: specialized medical care
care conditions: stationary
The form of medical care: emergency, emergency
Average treatment time (number of days): 14
Code ICD-X * Nosological unit
A08.0 rotavirus enteritis
A08.1 Acute gastroenteropathy caused by infection Norwalk
A08.2 adenoviral enteritis
A08.3 Other viral enteritis
A08.4 Viral intestinal infection, unspecified
1. Medical interventions to diagnose the disease, condition,
Reception (examination, consultation), a specialist doctor | |||
Code of medical services |
Name of medical services |
The average rate of frequency(1) |
The average index of the multiplicity of application |
B01.003.001 |
Inspection (consultation) anaesthesiologist-resuscitator primary |
0,15 |
1 |
B01.004.001 |
Reception (examination, consultation) gastroenterologist primary |
0,1 |
1 |
B01.010.001 |
Reception (examination, consultation), a pediatrician surgeon primary |
0,15 |
1 |
B01.014.001 |
Reception (examination, consultation), an infectious disease physician primary |
1 |
1 |
B01.015.003 |
Reception (examination, consultation), a pediatrician cardiologist primary |
0,1 |
1 |
B01.023.001 |
Reception (examination, consultation) neurologist primary |
0,2 |
1 |
B01.028.001 |
Reception (examination, consultation), ENT physician primary |
0,1 |
1 |
B01.029.001 |
Reception (examination, consultation) ophthalmologist primary |
0,05 |
1 |
B01.031.001 |
Reception (examination, consultation) pediatrician primary |
0,5 |
1 |
Laboratory Methods | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A09.05.037 |
Investigation of the hydrogen ion concentration (pH) of blood |
0,15 |
1 |
A09.05.038 |
Study osmolality level (osmolality) Blood |
0,1 |
1 |
A09.05.209 |
The study of blood procalcitonin |
0,25 |
1 |
A09.19.001 |
Fecal occult blood test |
1 |
1 |
A09.19.009 |
Fecal culture protozoa and helminth eggs |
1 |
1 |
A09.23.001 |
Cytological examination of cerebrospinal fluid cells |
0,05 |
1 |
A09.23.002 |
Determination of blood in the cerebrospinal fluid |
0,05 |
1 |
A09.23.003 |
Investigation of glucose in the cerebrospinal fluid |
0,05 |
1 |
A09.23.004 |
Investigation of protein levels in cerebrospinal fluid |
0,05 |
1 |
A09.23.006 |
Investigation of the physical properties of cerebrospinal fluid |
0,05 |
1 |
A09.23.007 |
Investigation of the hydrogen ion concentration (pH) in the cerebrospinal fluid |
0,05 |
1 |
A09.23.008 |
Microscopic examination of the cerebrospinal fluid, cell counting in a counting chamber (determination of cell count) |
0,05 |
1 |
A12.05.005 |
Identification of major blood groups (A, 0) |
0,05 |
1 |
A12.05.006 |
Determination of Rh Facilities |
0,05 |
1 |
A12.05.015 |
bleeding time study |
0,5 |
1 |
A12.06.011 |
Reacting Wasserman (RW) |
0,01 |
1 |
A12.19.001 |
Serological examination of feces |
1 |
1 |
A26.01.017 |
Microscopic examination of prints from the skin folds on the perianal pinworm eggs (Enterobius vermicularis) |
1 |
1 |
A26.05.001 |
Bacteriological examination of blood for sterility |
0,1 |
1 |
A26.06.034 |
Determination of antibody class M, G (IgG, IgM) to HAV (Hepatitis A virus) in blood |
0,05 |
1 |
A26.06.040 |
Determination of antibody class M, G (IgM, IgG) antigen of hepatitis B (HBsAg Hepatitis B virus) in blood |
0,05 |
1 |
A26.06.041 |
Determination of antibody class M, G (IgM, IgG) to the viral HCV (Hepatitis Cvirus) Blood |
0,05 |
1 |
A26.06.048 |
Determination of antibody class M, G (IgM, IgG) to human immunodeficiency virus HIV-1 (Human immunodeficiency virus HIV 1) in the blood |
0,05 |
1 |
A26.06.049 |
Determination of antibody class M, G (IgM, IgG) to human immunodeficiency virus HIV-2 (Human immunodeficiency virus HIV 2) in the blood |
0,05 |
1 |
A26.06.073 |
Determination of antibodies to enteric Salmonella (Salmonella enterica) Blood |
1 |
1 |
A26.06.074 |
Determination of antibodies to Salmonella paratyphi A (Salmonella paratyphy A) in the blood |
1 |
1 |
A26.06.075 |
Determination of antibodies to Salmonella paratyphi B (Salmonella paratyphy B) in blood |
1 |
1 |
A26.06.076 |
Determination of antibodies to Salmonella paratyphi C (Salmonella paratyphy C) in the blood |
1 |
1 |
A26.06.077 |
Determination of antibodies to Salmonella typhi (Salmonella typhi) Blood |
1 |
1 |
A26.06.086 |
Determination of antibodies to serovar enterokolitika Yersinia (Yersinia enterocolitica) Blood |
0,1 |
1 |
A26.06.093 |
Determination of antibody class M, G (IgM, IgG) to Yersinia enterokolitika (Yersiniaenterocolitica) Blood |
0,1 |
1 |
A26.06.094 |
Determination of antibody class M, G (IgM, IgG) to Yersinia pseudotuberculosis (Yersiniapseudotuberculosis) Blood |
0,1 |
1 |
A26.06.095 |
Determination of antibody class M, G (IgM, IgG) to Shigella Bodie (Shigella boudii) Blood |
1 |
1 |
A26.06.096 |
Determination of antibody class M, G (IgM, IgG) to Shigella dysentery (Shigelladysenterie) Blood |
1 |
1 |
A26.06.097 |
Determination of antibody class M, G (IgM, IgG) to Shigella sonnei (Shigella zonnei) Blood |
1 |
1 |
A26.06.098 |
Determination of antibody class M, G (IgM, IgG) to Shigella flexneri (Shigella fplexneri) Blood |
1 |
1 |
A26.19.001 |
Bacteriological examination of feces for the causative agent of dysentery (Shigella spp.) |
1 |
2 |
A26.19.002 |
Bacteriological examination of feces for typhoid-parathyphoid microorganisms (Salmonella typhi) |
1 |
2 |
A26.19.003 |
Bacteriological examination of feces for salmonella (Salmonella spp.) |
1 |
2 |
A26.19.004 |
Bacteriological examination of feces for Yersinia (Yersinia spp.) |
0,1 |
1 |
A26.19.005 |
Bacteriological examination of feces for campylobacter (Campylobacter spp.) |
1 |
1 |
A26.19.006 |
Bacteriological examination of feces for cholera (Vibrio spp.) |
0,2 |
1 |
A26.19.008 |
Bacteriological examination of feces for aerobic and facultative anaerobic microorganisms |
1 |
2 |
B03.016.003 |
Total (clinical) blood test detailed |
1 |
1 |
B03.016.004 |
Biochemical analysis of blood Obshcheterapevtichesky |
1 |
1 |
B03.016.006 |
Urinalysis total |
1 |
1 |
B03.016.010 |
scatological study |
1 |
1 |
Instrumental methods of research | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A04.06.002 |
Ultrasound examination of the lymph nodes (one anatomical area) |
0,2 |
1 |
A04.10.002 |
echocardiography |
0,1 |
1 |
A04.16.001 |
Ultrasound examination of the abdominal cavity (complex) |
0,2 |
1 |
A04.23.001.001 |
Ultrasound of brain research |
0,05 |
1 |
A04.28.001 |
Ultrasound examination of the kidneys and adrenal glands |
0,2 |
1 |
A05.10.006 |
electrocardiogram |
1 |
1 |
A05.23.001 |
Electroencephalography |
0,05 |
1 |
A06.09.007 |
radiography |
0,1 |
1 |
A06.30.004 |
Panoramic shot of the abdomen and pelvic organs |
0,05 |
1 |
Surgical, endoscopic, and endovascular other treatments requiring anesthetic and / or resuscitative accompaniment | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A11.23.001 |
spinal tap |
0,05 |
1 |
B01.003.004.001 |
Local anesthesia |
0,05 |
1 |
2. Medical services for the treatment of diseases, conditions and monitor treatment
Reception (examination, consultation) and specialist doctor supervision | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
B01.003.003 |
Daily monitoring anaesthesiologist-resuscitator |
0,05 |
4 |
B01.010.002 |
Reception (examination, consultation), a pediatrician surgeon re |
0,1 |
1 |
B01.014.003 |
Daily inspection infectious disease with the supervision and care of middle and junior medical staff in a hospital ward |
1 |
13 |
B01.015.004 |
Reception (examination, consultation), a pediatrician cardiologist re |
0,01 |
1 |
B01.017.001 |
Reception (consulting) physician-clinical pharmacologist |
0,1 |
1 |
B01.031.002 |
Reception (examination, consultation) pediatrician re |
0,5 |
1 |
B01.054.001 |
Inspection (consultation) doctor-physiotherapist |
0,3 |
1 |
Laboratory Methods | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A08.05.008 |
The study of blood reticulocytes |
0,25 |
1 |
A09.05.032 |
Investigation of the total calcium level in blood |
0,8 |
1 |
A09.05.209 |
The study of blood procalcitonin |
0,01 |
1 |
A09.19.001 |
Fecal occult blood test |
0,1 |
1 |
A09.19.005 |
Investigation of the hydrogen ion concentration (pH) in the stool |
0,15 |
1 |
A09.19.011 |
The study of feces for the presence of Clostridium difficile toxin (Slostridium difficile) |
0,25 |
1 |
A26.05.016 |
A study of intestinal microbiocenosis (dysbiosis) |
0,1 |
1 |
A26.19.009 |
Mycological examination of feces on the fungi of the genus Candida (Candida spp.) |
0,5 |
1 |
A26.30.004 |
Determination of the sensitivity of microorganisms to antibiotics and other drugs |
0,025 |
1 |
A26.30.006 |
Determination of microbial sensitivity to bacteriophages |
0,025 |
1 |
B03.016.002 |
Total (clinical) blood test |
0,5 |
1 |
B03.016.003 |
Total (clinical) blood test detailed |
1 |
2 |
B03.016.004 |
Biochemical analysis of blood Obshcheterapevtichesky |
1 |
1 |
B03.016.006 |
Urinalysis total |
1 |
2 |
B03.016.010 |
scatological study |
1 |
3 |
Instrumental methods of research | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A04.06.002 |
Ultrasound examination of the lymph nodes (one anatomical area) |
0,2 |
1 |
A04.14.001 |
Ultrasound examination of the liver |
0,5 |
1 |
A04.14.002 |
Ultrasonic examination of the gallbladder |
0,5 |
1 |
A04.15.001 |
Ultrasound examination of the pancreas |
0,5 |
1 |
A04.28.001 |
Ultrasound examination of the kidneys and adrenal glands |
0,2 |
1 |
A05.10.006 |
electrocardiogram |
1 |
1 |
Drug-free methods of prevention, treatment and medical rehabilitation | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A17.01.002 |
Influence on acupuncture points other physical factors |
0,05 |
5 |
A17.19.001 |
Electrophoresis medicines for intestinal disorders |
0,15 |
10 |
A17.30.007 |
Exposure to electromagnetic radiation in the centimeter range (SMV-therapy) |
0,01 |
5 |
A17.30.008 |
Exposure to electromagnetic radiation of a millimeter wave (EHF Therapy) |
0,01 |
5 |
A17.30.018 |
Exposure to electromagnetic radiation decimeter (SCM) |
0,01 |
5 |
A17.30.019 |
Exposure to an alternating magnetic field (AMF) |
0,01 |
5 |
3. The list of drugs for medical use, registered on the territory of the Russian Federation, with an indication of the mean daily dose courses
The code |
Anatomical Therapeutic Chemical Classification System |
Name of the drug ** |
The average rate of frequency |
Units |
SSD *** |
SKD **** |
A03AA |
Synthetic anticholinergics, esters with tertiary amino group |
0,1 |
||||
mebeverin |
mg |
400 |
2000 |
|||
A03AD |
Papaverine and its derivatives |
1 |
||||
Drotaverinum |
mg |
120 |
600 |
|||
Papaverine |
mg |
30 |
100 |
|||
A03FA |
Stimulants motor gastrointestinal tract |
1 |
||||
domperidone |
mg |
30 |
150 |
|||
metoclopramide |
mg |
5 |
50 |
|||
A07BC |
Absorbent intestinal drugs other |
1 |
||||
lignin hydrolysis |
mg |
1200 |
7200 |
|||
dioctahedral smectite |
mg |
9000 |
45000 |
|||
A07FA |
antidiarrheal microorganisms |
1 |
||||
bifidobacteria bifidum |
dose |
15 |
150 |
|||
Batsillyus Subtilis |
ml |
105 |
525 |
|||
Bifidobacteria bifidum + Lysozyme |
dose |
15 |
150 |
|||
Lactobacillus acidophilus + kefir fungi |
capsule |
3 |
42 |
|||
saccharomyces boulardii |
mg |
500 |
5000 |
|||
A10AB |
Short-acting insulins and analogues for injection into |
0,1 |
||||
Insulin Soluble (human genetically engineered) |
ED |
4 |
20 |
|||
A12CX |
Other minerals |
0,5 |
||||
Potassium and magnesium aspartate |
ml |
5 |
25 |
|||
B01AB |
Group heparin |
1 |
||||
heparin sodium |
IU |
25000 |
250000 |
|||
B05AA |
Blood substitutes and blood plasma |
0,4 |
||||
human albumin |
ml |
100 |
300 |
|||
Hydroxyethyl starch |
ml |
200 |
600 |
|||
B05BB |
Solutions affecting the water-electrolyte balance |
1 |
||||
Dextrose + + Potassium Chloride Magnesium Chloride Sodium Acetate + + Sodium gluconate + Sodium chloride |
ml |
200 |
800 |
|||
Dextrose + + Potassium chloride Sodium chloride + Sodium citrate |
ml |
200 |
600 |
|||
Meglumine sodium succinate |
ml |
200 |
600 |
|||
Sodium lactate solution complex (Potassium chloride + + Calcium chloride Sodium chloride + Sodium lactate) |
ml |
200 |
600 |
|||
sodium chloride complex (chloride Potassium + Calcium chloride + sodium chloride) |
ml |
200 |
800 |
|||
B05CX |
Other irrigation solutions |
1 |
||||
Dextrose |
ml |
1000 |
6000 |
|||
B05XA |
electrolyte solutions |
1 |
||||
potassium chloride |
mg |
50 |
200 |
|||
Sodium chloride |
ml |
400 |
1600 |
|||
C01BB |
local anesthetics |
0,05 |
||||
lidocaine |
mg |
100 |
1000 |
|||
C05AD |
local anesthetics |
0,5 |
||||
procaine |
mg |
20 |
300 |
|||
H02AB |
glucocorticoids |
0,15 |
||||
dexamethasone |
mg |
5 |
40 |
|||
methylprednisolone |
mg |
25 |
200 |
|||
hydrocortisone |
mg |
50 |
200 |
|||
prednisolone |
mg |
25 |
100 |
|||
J01DD |
Cephalosporins 3 gopokoleniya |
0,4 |
||||
cefotaxime |
mg |
1000 |
14000 |
|||
ceftriaxone |
mg |
1000 |
5000 |
|||
J01GB |
other aminoglycosides |
0,1 |
||||
amikacin |
mg |
1000 |
7000 |
|||
J02AC |
triazole derivatives |
0,2 |
||||
fluconazole |
mg |
150 |
750 |
|||
J05AX |
Other antivirals |
0,25 |
||||
Methylphenylthiomethyl gidroksibromindol-dimethylaminomethyl-carboxylic acid ethyl ester |
mg |
400 |
2000 |
|||
J06BA |
Normal human Immunoglobulins |
0,05 |
||||
Normal human immunoglobulin |
mg |
5000 |
15000 |
|||
L03AX |
other immunostimulants |
0,1 |
||||
azoximer bromide |
mg |
6 |
30 |
|||
M01AE |
Propionic acid |
0,7 |
||||
ibuprofen |
mg |
200 |
2000 |
|||
N01BB |
Amides |
0,05 |
||||
lidocaine |
mg |
100 |
100 |
|||
N02BB |
pyrazolones |
0,7 |
||||
metamizole |
mg |
500 |
1500 |
|||
N02BE |
anilides |
0,3 |
||||
Paracetamol |
mg |
500 |
1500 |
|||
N05BA |
benzodiazepines |
0,2 |
||||
diazepam |
mg |
10 |
50 |
|||
R06AE |
piperazine derivatives |
0,2 |
||||
cetirizine |
mg |
10 |
70 |
|||
R06AX |
Other systemic antihistamines |
0,2 |
||||
loratadine |
mg |
10 |
70 |
|||
V06DD |
Amino acids, including combinations of the polypeptides |
0,3 |
||||
Amino acids for parenteral nutrition |
ml |
200 |
600 |
4. Kinds of medical supplies, including specialized therapeutic food
Name of Clinical Nutrition |
The average rate of frequency |
amount |
diet variant with mechanical and chemical schazheniya |
1 |
14 |
* - International Statistical Classification of Diseases and Related Health X review
** - international nonproprietary or chemical name of the drug, and in their absence - the trade name of the drug
*** - average daily dose
**** - average course dose
Remarks:
1. Medicinal products for medical use, registered on the territory of the Russian Federation shall be appointed in accordance with the instructions for use of the drug for medical use and for pharmacotherapeutic group Anatomical Therapeutic Chemical Classification System, recommended by the World Health Organization, as well as the route of administration and application of the drug. When assigning of medicaments for the medical use children dose is determined taking into account the mass body age in accordance with the instructions for use of the drug for medical application.
2. Purpose and use of drugs for medical use, medical devices and specialized clinical nutrition products are not included in the standard of care, allowed in the case of medical indications (individual intolerance, for health reasons) by the decision of the medical commission (Part 5 of Article 37 of the Federal Law of November 21, 2011 № 323-FZ "On the basis of public health protection in the Russian Federation" (Collected Legislation of the Russian Federation, 2011, № 48, Art. 6724; 2012, number 26, Art. 3442, 3446)).
(1) the likelihood of providing medical services or prescribing for medical applications (medical devices) included in the standard of care that can take values from 0 to 1, where 1 indicates that the event is 100% of patients true to the model, and the figures at least 1 - indicated in the medical care of patients the standard percentage, with appropriate medical readings.
